Introduction
International comparisons have shown that the occurrence of coronary heart disease varies greatly from one country to another. In China the incidence of and mortality from coronary heart disease are low, as shown by, for example, the World Health Organisation monitoring trends and determinants in cardiovascular disease (MONICA) project.' The highest age standardised coronary heart disease mortality in men aged 35-64 years was found in the Siberian MONICA study (401/100 000) and the lowest in the Sino-MONICA-Beijing study (40/100000) . In women the highest coronary heart disease mortality was found in the Glasgow MONICA study (132/100000) whereas in Beijing it was only 28/100 000.' These 10-fold differences in men and 4-7-fold differences in women may be explained by different levels of coronary heart disease risk factors,2 but it has also been proposed that these risk factors may have different impact on the development of coronary heart disease in different geographic areas and in genetically different populations.
There have been many studies comparing coronary heart disease risk factor levels in different countries. [2] [3] [4] [5] [6] Genetics, ethnic background, lifestyles, and study methods have often differed between the areas, hence the possibilities for valid conclusions from many earlier comparisons are limited. The Ni-Hon-San (NipponHonolulu-San Francisco) Japanese migrant study initiated in the mid-1960s overcame many methodological shortcomings and showed a clear gradient in coronary heart disease mortality among Japanese men increasing from Japan to Hawaii and further to California, despite the subjects studied having the same genetic background.7'"
The epidemiological evidence suggests that the occurrence of coronary heart disease is largely determined by the environment.38' The aim of this study was to compare the prevalence of electrocardiographic abnormalities and to assess the association between these abnormalities and the levels of major coronary heart disease risk factors among Chinese living in two different environments: in Beijing, China, and in Mauritius. Migrant studies provide one of the best means ofgenerating hypotheses concerning the relation of environmental factors and disease. The island country of Mauritius, which has an entirely immigrant population, is an ideal place for migrant studies. The Chinese form one of three main ethnic groups in Mauritius.
Methods

STUDY POPULATION
The Sino-MONICA-Beijing study covers a population of approximately 700 000, about two thirds urban and one third rural, scattered in six urban and suburban districts and one rural county of Beijing. This distribution approximates that ofthe whole city. The independent effect and relative importance of several putative variables and their interactions on the occurrence of electrocardiographic abnormalities suggesting coronary heart disease among the Chinese were assessed using the multiple logistic regression model. In the final model, in addition to the population, we included age, non-high density lipoprotein cholesterol concentration, and mean arterial pressure, which in univariate analyses were associated with electrocardiographic abnormalities. To assess whether the observed difference in the association of these three risk factors with electrocardiographic abnormalities was different between the Chinese living in China and in Mauritius, we included interaction terms between centre and other variables in the multiple logistic regression model.
Results
The prevalence of electrocardiographic abnormalities suggesting coronary heart disease was low in all study populations (table I). Since the prevalence of possible coronary heart disease was also low in Beijing, the overall prevalence of positive electrocardiographic findings (probable and possible coronary heart disease) was significantly lower in Beijing (4 0%) than in Mauritian Chinese (24-3%) and in Mauritian nonChinese (24 5%). The prevalence of possible coronary heart disease was higher in women than in men in each population because ST-T changes (such as 4-2, 43, 5-2, 5 3) were more common in women than in men. The prevalence of abnormal electrocardiogram was significantly lower in the younger (35 to 54 years) than older (55 to 64 years) subjects among the three populations (table II) .
In Beijing, men with a positive electrocardiogram had significantly higher serum total cholesterol and non-high density lipoprotein cholesterol concentrations, higher systolic and diastolic blood pressures, and a higher prevalence of hypertension than men with a normal electrocardiogram (table III) . Only systolic blood pressure was significantly higher in women with a positive electrocardiogram compared with those with a normal electrocardiogram. In Mauritian Chinese, non-high density lipoprotein cholesterol concentration, body mass index, systolic blood pressure, and the prevalence of hypertension were significantly greater in men with electrocardiographic abnormalities than in those without. In women, only the prevalence of hypertension was higher in subjects with a positive electrocardiogram. In the non-Chinese population of Mauritius both men and women with a positive electrocardiogram had significantly increased systolic and diastolic blood pressures and prevalence of hypertension.
In Mauritius, about 40% of the Chinese subjects with an abnormal electrocardiogram had a high blood pressure (table IV) . Because ofrelatively small numbers and similar trends in both sexes data for men and women were pooled. The overall association between electrocardiographic abnormalities and hypertension was similar in younger (35 to 54 year old) and older (55 to 64 year old) subjects. In both populations the increase in the prevalence of electrocardiographic BMJ VOLUME 304 abnormalities with age was parallel with the increase in the prevalence of hypertension.
The multiple logistic regression analysis confirmed that the higher prevalence of electrocardiographic abnormalities was not fully explained by the differences in serum non-high density lipoprotein cholesterol concentration and blood pressure (table V). The interaction between the study area (Beijing v Mauritius) and the three risk factors was non-significant confirming that their effect was similar in both Chinese populations and both in men and women.
Discussion
The present study provides a unique opportunity to assess the risk of coronary heart disease in the Chinese, who in their homeland are known for their low incidence of and mortality from coronary heart disease.' '" Although increasing evidence is accumulating on the importance of genetic susceptibility to the risk of coronary heart disease,"6'" genetic markers that might contribute to the lower coronary heart disease risk in the Chinese have not been identified. People of Mongoloid origin, including the Chinese, are particularly susceptible to hypertension, non-insulin dependent diabetes mellitus, and stroke if exposed to environmental risk factors.' 1319-22 Therefore, the apparent lower susceptibility to coronary heart disease in China remains obscure and is probably related to lifestyles and culture.
The main finding of our study was that the prevalence of coronary heart disease in Even though absolute levels of blood pressure and plasma lipids in Mauritian Chinese in our study were not exceptionally high, they were by no means low, and were similar to those of the Indian and Creole Mauritians. Earlier studies have shown that Chinese patients with acute myocardial infarction have significantly higher blood pressure and plasma lipid concentrations than do control subjects.33" This is consistent with the commonly agreed fact that the risk of coronary heart disease increases linearly with blood pressure and plasma cholesterol.335 36 Other factors than may account for the higher rate of coronary heart disease in Chinese in Mauritius than in Beijing could be differences in dietary habits and physical activity that are likely to be more favourable in Beijing,37 38 although comparative data are not available.
CORONARY HEART DISEASE
The World Health Organisation MONICA project baseline data showed that mortality from coronary heart disease among the 40 participating centers was the lowest in men from Beijing, and although the Chinese women did not rank the lowest, their absolute rate was low.' The reported incidence (attack rate) of acute myocardial infarction-26/100000/year in men and 8/100000/year in women aged 25-64-confirmed that the true occurrence of acute myocardial infarction is very low."5 We studied the same population in Beijing, and can thus be confident that the low prevalence of coronary heart disease shown by our survey reflects a low incidence of coronary heart disease in mainland China.
Repolarisation findings in electrocardiograms are not specific for coronary heart disease but can also be related to other conditions, such as carditis; they can also be due to automatic influences, chest configuration, obesity, and the fasting state. Electrocardiograms are, however, often used in cardiovascular surveys to provide estimates for the occurrence of coronary heart disease. Particularly in developing countries, where epidemiological studies of coronary heart disease are rare, a cross sectional analysis of electrocardiographic abnormalities will often be the only feasible way to obtain such information. Although these do not provide a complete picture of the occurrence of coronary heart disease in the population, they are valuable for determining the subsequent risk for coronary heart disease.3943 CONCLUSIONS Our data confirm the previous observation based on routine statistics that coronary heart disease is common in Mauritius" and they show that heart disease is certainly important in the Chinese community. Similarly, it is a major public health problem in the Chinese population of Singapore (where rates are already higher than in Australia), the United States, and many European countries.4546 Therefore primordial prevention of coronary heart disease in the People's Republic of China is the major challenge for preventive medicine there.'24748 We believe that the situation seen in Singapore and Mauritius is not inevitable and that it is possible to prevent such a major epidemic of coronary heart disease from occurring in China. Further assessment of trends in coronary heart disease mortality, morbidity, and risk factors will show whether this will be successful in reality. Results-Among children with brain tumour, five (11%) who received growth hormone had recurrences compared with 42 (26%) who did not receive growth hormone. Also adjusting for other variables that might affect tumour recurrence the estimated relative risk of recurrence was 0-82 (95% confidence interval 0*28 to 2 37). The only child with acute lymphoblastic leukaemia who relapsed while taking growth hormone had relapsed previously before starting treatment. Two of the five children with brain tumours who relapsed had abnormal appearances on computed tomography when growth hormone was started. 14 other children who remained relapse free and had follow up computed tomography showed no deterioration in radiological appearance during treatment.
Conclusions-In this population growth hormone did not increase the risk of tumour recurrence but continued surveillance is essential. Abnormal results on computed tomography are not a contraindication to treatment with growth hormone.
Introduction
Acute lymphoblastic leukaemia and brain tumours are the two commonest childhood malignancies, the treatment of which has consisted of cranial irradiation with or without adjuvant cytotoxic chemotherapy. Long term management of the endocrine sequelae of treatment, including growth failure, is fundamental to the improved quality of life of these children. The use of growth hormone in children with radiation induced growth hormone deficiency is now widely accepted, but questions still exist about the safety of this mitogenic hormone and whether it might cause a recurrence of a brain tumour or leukaemia.
Studies with small numbers of patients at our centre' and others23 suggested that growth hormone is not responsible for recurrence of brain tumours, but none of these studies applied statistical analysis. An analysis of deaths in recipients of pituitary growth hormone showed brain tumour recurrence to be one of the most common causes, but a comparative group who had not received growth hormone was not available for analysis.4 Therefore, it could not be established whether growth hormone contributed to tumour recurrence.
In children treated with growth hormone after treatment for a brain tumour radiographs of the central nervous system often appear abnormal at the start of treatment. No information is available to determine if
